| Nanoplasmonic sandwich immunoassay for tumor-derived exosome detection and exosomal PD-L1 profiling C Wang, CH Huang, Z Gao, J Shen, J He, A MacLachlan, C Ma, Y Chang, ... ACS sensors 6 (9), 3308-3319, 2021 | 43 | 2021 |
| Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein X Kang, J Wang, CH Huang, FS Wibowo, R Amin, P Chen, F Li Nanomedicine: Nanotechnology, Biology and Medicine 47, 102620, 2023 | 17 | 2023 |
| Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems X Kang, S Jadhav, M Annaji, CH Huang, R Amin, J Shen, CR Ashby Jr, ... Pharmaceutics 15 (6), 1567, 2023 | 9 | 2023 |
| Metal–Organic Nanomaterials for Drug Delivery CH Huang, P Chen, XM Liu, F Li Polymers in Therapeutic Delivery, 79-95, 2020 | 4 | 2020 |
| Novel sulindac derivatives for colorectal cancer chemoprevention that target cGMP phosphodiesterases to suppress Wnt/β-catenin transcriptional activity S Ramesh, P Johnson, K Fadlalla, A Moore, CH Huang, K Berry, ... Cancer Insight 3 (1), 42-54, 2023 | 2 | 2023 |
| Elesclomol-Copper Nanoparticles Overcome Multidrug Resistance in Cancer Cells Q Wang, C Huang, FS Wibowo, R Amin, J Shen, F Li, RJ Babu ACS Applied Materials & Interfaces 16 (11), 13509-13524, 2024 | 1 | 2024 |
| A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer JB Foote, TE Mattox, AB Keeton, X Chen, FT Smith, KL Berry, T Holmes, ... bioRxiv, 2023.05. 17.541233, 2023 | 1 | 2023 |
| Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth X Kang, Q Wang, S Wu, C Wang, M Annaji, CH Huang, J Shen, P Chen, ... Biomolecules 13 (5), 744, 2023 | 1 | 2023 |
| ADT-007 binds RAS and inhibits RAS signaling AB Keeton, X Chen, J Valiyaveettil, CH Huang, TE Mattox, K Fadlalla, ... Cancer Research 83 (7_Supplement), 1658-1658, 2023 | 1 | 2023 |
| Abstract LB322: Antitumor activity of 1st-in-class pan-RAS inhibitor ADT-1004 in mouse models of pancreatic ductal adenocarcinoma YY Maxuitenko, JB Foote, AB Keeton, X Chen, K Berry, K Fadlalla, ... Cancer Research 83 (8_Supplement), LB322-LB322, 2023 | | 2023 |
